An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Morgan Stanley Announces 11% Dividend Increase and Authorization of a $20 Billion Multi-Year Common Equity Share Repurchase Program
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
buybackdividends
Rhea-AI Summary
Morgan Stanley (NYSE: MS) has announced an increase in its quarterly common stock dividend from $0.70 to $0.775 per share, effective from the third quarter of 2022. Additionally, the Board has approved a new multi-year common equity share repurchase program of up to $20 billion, set to begin in the same quarter. This initiative aims to enhance shareholder value, reflecting the firm's ongoing commitment to returning capital while maintaining a strong capital position with a CET1 ratio of 13.3%.
Positive
Increased quarterly common stock dividend from $0.70 to $0.775 per share, an 11% rise.
Authorized a $20 billion multi-year share repurchase program to boost shareholder value.
Strong capital position with a CET1 ratio of 13.3%, providing flexibility for investments and returns.
Negative
Subject to a Stress Capital Buffer (SCB) of 5.8% from October 1, 2022, which may affect future capital management.
NEW YORK--(BUSINESS WIRE)--
Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.775 per share from the current $0.70 per share, beginning with the common dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2022.
In addition, the Firm’s Board of Directors authorized a new multi-year common equity share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter of 2022. The share repurchases will be exercised from time to time at prices the Company deems appropriate, subject to various considerations, including current market conditions, the Firm’s capital position and future economic and earnings outlook.
James P. Gorman, Chairman and Chief Executive Officer of Morgan Stanley, said, “We are pleased to continue our robust capital return program, which is driven by our business transformation, especially the durable earnings from our Wealth Management and Investment Management businesses. After doubling our dividend last year, we are raising our dividend 11% and continuing to buy our stock under a new $20 billion multi-year share repurchase authorization. The strength and stability of our franchise and our capital cushion provide us the flexibility to continue to invest for future growth while also returning capital to shareholders.”
On June 23, 2022, the Board of Governors of the Federal Reserve System released its CCAR 2022 results, as a result of which Morgan Stanley will be subject to a Stress Capital Buffer (SCB) of 5.8% from October 1, 2022 to September 30, 2023. Together with other features of the regulatory capital framework, this SCB results in an aggregate U.S. Basel III Standardized Approach Common Equity Tier 1 (CET1) ratio of 13.3%. The Firm’s U.S. Basel III Standardized Approach CET1 ratio was 14.5% as of March 31, 2022.
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 41 countries, the Firm's employees serve clients worldwide including corporations, governments, institutions, and individuals. For more information about Morgan Stanley, please visit www.morganstanley.com.
Forward-Looking Statements
This release contains forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made, which reflect management’s current estimates, projections, expectations, assumptions, interpretations or beliefs and which are subject to risks and uncertainties that may cause actual results to differ materially. Morgan Stanley does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise after the date of forward-looking statements. For a discussion of additional risks and uncertainties that may affect the future results, financial position or capital of Morgan Stanley, please see “Forward-Looking Statements” preceding Part I, Item 1, “Competition” and “Supervision and Regulation” in Part I, Item 1, “Risk Factors” in Part I, Item 1A, “Legal Proceedings” in Part I, Item 3, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 and “Quantitative and Qualitative Disclosures about Risk” in Part II, Item 7A, in Morgan Stanley’s Annual Report on Form 10-K for the year ended December 31, 2021 and other items throughout the Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, including any amendments thereto.